Abstract
Thirty-seven eligible patients with advanced non-Hodgkin's lymphoma of low-grade, T-cell intermediate- and high-grade histology were treated with pentostatin (2'-deoxycoformycin, dCF) 4mg/m2 i.v. weekly for 3 weeks and then every 14 days to be followed after 3 doses by the same dosage every 4 weeks until maximum response or progression. Only patients with no more than two chemotherapy regimens were entered in this trial. All patients had measurable disease, performance status of 1,0 and 2 and adequate bone marrow, renal and liver function. Five of 37 eligible patients experienced a partial response of 8 months' median duration (range 7-12). The response rate was 17% in low-grade, 8% in T-cell intermediate- and high-grade and 14% in cutaneous T cell lymphoma. The only eligible patient with Hodgkin's disease underwent progression while on treatment. One case presented with grade 3 leukopenia and another one died of septicaemia, possibly treatment-related. Elevated but reversible creatinine levels were observed in 13% of patients and conjunctivitis in 7%. The toxicity of dCF at this low-dose schedule was acceptable, but the therapeutic activity in pretreated patients with low-grade, T-cell intermediate- and high-grade and cutaneou...Continue Reading
Citations
Aug 10, 2000·British Journal of Haematology·D AldinucciA Pinto
Mar 28, 2006·Future Oncology·Anthony D Ho, Manfred Hensel
Dec 3, 2005·Leukemia & Lymphoma·Fadi BraitehRazelle Kurzrock
Jan 27, 2016·Critical Reviews in Oncology/hematology·Pier Luigi ZinzaniStefano Pileri
Dec 15, 2010·Journal of the American Academy of Dermatology·Elise A OlsenMadeleine Duvic
Jan 13, 2004·Clinical Lymphoma·Robert DrapkinLina Asmar
Jan 2, 2007·Cancer Letters·Amit W Panwalkar, James O Armitage
Jan 27, 2005·Cancer·Nicholas Di BellaLina Asmar
Jan 13, 2004·Cancer·Apostolia-Maria TsimberidouRazelle Kurzrock
Dec 29, 2006·Pharmacotherapy·Jeffrey J Bruno, Todd W Canada
Dec 1, 2007·Hematological Oncology·Delvys Rodriguez-AbreuEmanuele Zucca
Jun 21, 2005·Blood Reviews·Farhad Ravandi, Susan O'Brien
Mar 22, 2006·Seminars in Hematology·Nicholas Di Bella, Farhad Ravandi
Sep 10, 2014·Cancer Treatment Reviews·Bertrand CoiffierPier Luigi Zinzani
Sep 7, 2014·Annals of Hematology·Pengpeng XuWeili Zhao
Jan 20, 2007·British Journal of Haematology·Nam H DangLuis Fayad
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip WentStefano A Pileri
Dec 8, 2015·Hematology·Madeleine Duvic
Oct 8, 2005·Blood·Mujahid A RizviSteven T Rosen